Table of Contents
Backup Visuals Presented
Study 901 - Number of Gd+ Lesions at Baseline
Study 901 - Summary of Relapse Data
Study 901 - Definition of Severe Relapse
Study 901 - Effect of Prior Relapses on Primary Efficacy Endpoints
Study 901 - Concomitant MS Medications Used by ? 5 Patients at Baseline
Study 902 - Gd-Enhancing Scans at Month 6 by 1.0 Point EDSS Deterioration
Study 902 - Correlation Between Gd+ Lesion and EDSS Score
Study 902 - Corticosteroid Use for Relapses
Study 901 - Disability Change Month 24 to 36
Study 902 - New Lesions on T2 Weighted Scans by Lesion Size
Study 903 - Infections
Study 901 - Infection and Hemorrhage
Study 901 - Chemistry Toxicity WHO Grade 3-4
Study 901: Month 36 Menstruation Data
Study 901 - Hospitalizations for Reasons Other Than Study Drug Administration
|